scib1
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01138410)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- scib1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04079166 | Phase 2 | Aug 19, 2019 | Scancell Ltd, University of Nottingham |
| NCT01138410 | Phase 1/Phase 2 (Phase 2) | May 1, 2010 | Moorgreen Hospital, Southampton, Scancell Ltd, The Christie NHS Foundation Trust, University of Leeds, University of London, University of Nottingham |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Scancell Ltd | For profit | 2 | 2 | 1 | 2010 |
| University of Nottingham | Academic/Hospital | 2 | 0 | 1 | 2010 |
| Moorgreen Hospital, Southampton | Academic/Hospital | 1 | 0 | 1 | 2010 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Leeds | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1